Navigation Links
GVI Security Solutions Provides Video Surveillance Solution for One of the Largest Health Care Organizations in Colombia
Date:4/9/2009

CARROLLTON, Texas, April 9 /PRNewswire-FirstCall/ -- GVI Security Solutions, Inc., (OTC Bulletin Board: GVSS), a leading provider of video security surveillance solutions featuring the complete Samsung Electronics line of products will provide a video surveillance solution including Samsung Electronics Cameras, DVRs and LCD Touch screen controllers for one of the largest health care organizations in Colombia.

"This extensive project, covering eight locations including hospitals, clinics and offices demonstrates the advantages of GVI Samsung solutions in health care settings," said Fernando Tomasiello, GVI Senior Vice President Int'l Operations and Sales. "The Samsung SSD-5000 LCD touch screen controller and SHR-5000 DVR combination provided the perfect monitoring, control and recording solution for an installation encompassing diverse clinical environments."

About GVI Security Solutions, Inc.

GVI Security Solutions, Inc. (OTCBB: GVSS) is a leading provider of video surveillance and security solutions, with sales and service representation throughout North, Central and South America. The company provides Samsung Electronics and GVI branded products, software and services to the Homeland Security and Commercial markets. Their customers include governments, major retail chains, leading financial institutions and public and private school systems.

Forward-Looking Statements:

Some of the statements made by GVI Security Solutions, Inc. in this press release are forward looking in nature. Forward-looking statements in this press release are not promises or guarantees and are subject to risks and uncertainties that could cause our actual results to differ materially from those anticipated. These statements are based on management's current expectations and assumptions and are naturally subject to uncertainty and changes in circumstances. We caution you not to place undue relianc
'/>"/>

SOURCE GVI Security Solutions, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Social Security Administration First to Go Live With CONNECT Solution for Nationwide Health Information Network
2. Edmond Scientific Company Demonstrates RHIO/HIE Data Security and Privacy Solution for the NHIN at Annual HIMSS Conference, Chicago 09
3. Social Security Disability Applicants' Wait for Benefits Continues
4. Living longer on less: The new economic (in)security of seniors in Massachusetts
5. Harsh Impact of Social Security Delays for People With Disabilities: United Spinal Associations Peggy Hathaway Testifies Before Congress
6. Lumension Unveils Optimal Security Podcast Series on iTunes
7. USAID Provides $3.7 million to Assist with Global Food Security in Senegal
8. Getting Social Security Disability Benefits Isn't Simple, Even After Approval
9. China Information Security Technology, Inc. Announces that Its Medical Case Statistics Software Selected for Exclusive Contract
10. PHARMORX Security And MSO Announce Joint Venture
11. Security Health Plan Becomes First ICSI Sponsor Outside of Minnesota

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...E,Calif.,Nov.25/PRNewswire-FirstCall/-- OnyxPharm...ecompanywillhosttwoinvestoreventsinDecember: ,,.../10:00a.m.ET ,, Principalinvestigatorswilldis...sedand/orrefractorymultiplemyeloma,asfeaturedatthe...ndExpositioninNewOrleans,LA.Theteleconferencewillb...
(Date:11/25/2009)...S,Nov.25/PRNewswire-USNewswire/--TheBlackAIDSInsti...eexecutiveleadershipfor2010. ,, ThenewBoardMemb...npublicpolicy,law,finance,governmenthealthprograms...ocomesfromawiderangeofpersonalbackgroundsincluding...ithHIVthemselves,andrepresentingmultipleagegroups....
(Date:11/25/2009)...discovery that grew out of a collaboration between...ffer hope to the nearly 10 million Americans who s...so known as hardening of the arteries, peripheral ...problem in which narrowed arteries reduce blood fl... flag for vascular disease, heart attack and strok...
(Date:11/25/2009)...lness could lead mothers to overlook needed care, ...thDay News) -- A mother,s depression can worsen he..., Their six-month study of 262 black mothers and t...d more depressive symptoms had more frequent asthm...epressive symptoms had less frequent asthma sympto...
(Date:11/25/2009)...mprovementShownforthe4thStraightYear ,, WASHI...ancerAlliance-Georgia(LCA-GA)issuedthe 4thAnnualRe...ogressbeingmadeagainstthislethaldiseaseinthestateo...,theonlynationalorganizationdedicatedexclusivelyto...skforlungcancer. ,, (Logo: http://www.newscom.c...
Breaking Medicine News(10 mins):Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Mom's Depression May Worsen Child's Asthma 2Health News:Lung Cancer Alliance-Georgia Issues 4th Annual State-Specific Report Card on Lung Cancer 2
...raveled a chemical correspondent of the human geno...mises to be a harbinger of novel ways of diagnosin...tion of the human body. The project costing $7.5 m...s, 1,200 drugs and 3,500 food components, present ...
...mune systems should not eat raw// or undercooked s...Health Canada. “Eat veggies full of vitamins a...nd green beans help to keep us strong, energetic a...been blamed for bringing on sickness and even deat...
...ull of food, and are seen to be overeating, just t... Earlier, the government had stipulated that any...d get the obesity surgery done, free of cost. This...th conditions like diabetes and blood pressure are...
...chrane Library journal concludes //that the three ...alis, Levitra and Viagra appear to be safe and eff...uded in a family of medications called phosphodies...more likely than other men to deal with ED problem...
...edure to combat obesity in adolescents,// accordin...It is the first study to evaluate the lap band in ... patients on average lost about 50% of their exces... only approved by the Food and Drug Administration...
...a three-year $2.1 million grant to researchers// a... a new drug to treat bipolar disorder. The g... the brain and block the mania associated with the...sorder include so-called 'mood stabilizers' -- lit...
Other Medicine News:Health News:Raw (or) Undercooked Sprouts May Carry Harmful Bacteria 2Health News:ED Drugs - Safe and Effective for Diabetic Men 2Health News:Stomach Banding Surgery Effective for Adolescents 2Health News:Stomach Banding Surgery Effective for Adolescents 3Health News:UIC Researchers Receive $2.1 Million Grant 2
(Date:11/25/2009)...stCall/--NuVasive,Inc.(Nasdaq: NUVA ),amedicaldevi...sruptivesurgicaltreatmentsforthespine,announcedtod...,2009,at5:30p.m.ET/2:30p.m.PT.Theconferencecallwil...Company,sproductsandwillincludecommentsfrommanagem...l-innumbersare1-877-407-4018fordomesticcallersand1...
(Date:11/25/2009)...portlinker.comannouncesthatanewmarketresearchrepor...elivery-USMarketTrends&Analysis http://www.re...-US-Market-Trends--Analysis.html ,, TheUSintra...erapeuticapplicationsfromthedeliveryofconventional...euticdrugs.Thefutureofthetechnologyhingesontotheef...
(Date:11/25/2009)...ewswire/-- ChemoCentryx,Inc.,announcedtodaythatPh...ProspectiveRandomizedOralTherapyEvaluationinCrohn,...swithmoderate-to-severeCrohn,sdiseasedemonstratedc...profile.Thestudydemonstratedevidenceofclinicaleffi...pointdecreaseintheCrohn,sDiseaseActivityIndex(CDAI...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Study finds colorectal cancer rates increasing worldwide 8769 1Study finds colorectal cancer rates increasing worldwide 8769 2Pharmacy Organizations Brief Congress on Medication Therapy Management 48343 1Pharmacy Organizations Brief Congress on Medication Therapy Management 48343 2Pharmacy Organizations Brief Congress on Medication Therapy Management 48343 3Lumbar Spinal Stenosis Surgery at the Olympia Medical Center 48340 1Lumbar Spinal Stenosis Surgery at the Olympia Medical Center 48340 2
... for Presentation at 47th ICAAC on ..., Sept. 4 Ardea Biosciences,Inc. (Pink Sheets: AR...eted,Phase 1 single-ascending-dose, multiple-ascen...es of RDEA806, a novel HIV non-nucleoside reverse,...eers. The data from these Phase 1 clinical trials...
...ive analysis of,clinical trials known as a meta-an...tent was associated with significantly lower risks...mpared to the Taxus Stent out to 30,months after a...randomized,clinical trials and 8,695 patients, the...ed on the Journal of the American College of Cardi...
Other Medicine Technology:Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806 2Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806 3Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent 2Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent 3Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent 4
Anterior Stromal Puncture Cannula, 25 g
Viscoelastic Cannula, 23 g. Angled
Anterior Chamber Needle, 21 g
Anterior Chamber Needle, 25 g. Angled
Medicine Products: